Manager, Delivery and Sensing Development
Suite 201, Level 2, 3 Chester Street
61 (3) 95673703
61 (3) 95681214
Click here to visit Web Site
Dr Michelle Critchley has joined Nanotechnology
Victoria on a full-time basis from January 1st 2008. Michelle commenced
with NanoVic in 2004
on secondment from CSIRO to work on bio-nano related projects with Dr Bob Irving
and the Sensing & Delivery team. Since then, Michelle has been an important
contributor to NanoVic’s
capabilities, particularly through her understanding of the impact of nanostructured
materials on biological systems. Her research at CSIRO spanned a variety of
client industries including biotechnology, aerospace, food safety, Legionella
control and biosensor development.
At NanoVic, Michelle
has led several major projects including the Transdermal Delivery Project on
novel drug and vaccine delivery mechanisms with the Victorian College of Pharmacy,
and the Nanoparticle Diagnostics Project with RMIT University. She has also
supported the nanostructured materials team in the development of anti-bacterial
surfaces and tools, where her environmental and public health risk assessment
expertise was invaluable.
Michelle was awarded the ASCEPT prize in 1997 and the Australasian Corrosion
Association AMAC Award in 2000. In June 2007, Michelle was awarded one of the
prestigious Australian Academy grants to undertake international collaborative
research. She used this to collaborate with the USA Centre for Management, Protection
and Utilization of Water Resources at the Technical University of Tennessee
in August 2007. Michelle was also an author of a Special Report: Nanotechnology:
the Next Wave of Commercial Development for Health and Medical Devices - The
Australian Story in Nanomedicine 2(2) in April 2007, with Dr Bob Irving and
Dr Jeanette Pritchard.
Michelle is active in developing new technologies, particularly around transdermal
delivery of nanoparticle medicines. Together with Dr Bob Irving of NanoVic,
Professor Colin Pouton and Dr Paul White of Victorian College of Pharmacy, Michelle
is an inventor on the patent application (PCT: WO 2007/012114 lodged July 2006)
for the transdermal delivery MicroArray Device. Further developments will be
protected and announced in the near future.
Over the last year, Michelle has been completing a Masters in Intellectual
Property Law, and is already playing a role in NanoVic’s
IP management. Michelle also contributes to NanoVic’s
educational activities and to initiatives with NanoSafe Australia. Michelle
is a participant in the 2007 DEST Scientists in Schools Program, promoting science
in Victorian primary schools.
Michelle has taken leave from CSIRO, and joins NanoVic
full-time as Manager Operations for the Interstitial
NS drug delivery venture. In this capacity, she has taken responsibility
for development of the Interstitial
Business Plan and leading the commercialization activities for this portfolio.
Michelle was awarded the ASCEPT prize in 1997 and the Australasian Corrosion Association AMAC Award in 2000. In addition to her project activities, Michelle contributes to educational and public awareness initiatives for biotechnology and nanotechnology. Michelle has an undergraduate degree in Environmental Health from the Flinders University of South Australia, and a PhD in Environmental Microbiology, obtained from the same institution.
Fee Charging structure and rates
Please contact for further information.
Availability and preferred contact route
Current availability status